The putative serine protease inhibitor Api m 6 from Apis Mellifera venom: Recombinant and structural evaluation

Journal of Investigational Allergology and Clinical Immunology

Volumn 22, Issue 7, 2012, Pages 476-484

  Michel, Y ^a   McIntyre, M ^b   Ginglinger, H ^a   Ollert, M ^b   Cifuentes, L ^b   Blank, S ^a   Spillner, E ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Api m 6; Apis mellifera; Honeybee venom; Hymenoptera venom; Insect venom allergy; Protease inhibitor; Recombinant allergen; SigE

Indexed keywords

ALLERGEN; API M 6; BEE VENOM; EPITOPE; IMMUNOGLOBULIN E; RECOMBINANT PROTEIN; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

APIS MELLIFERA; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; IMMUNOCHEMISTRY; IMMUNOREACTIVITY; INSECT ALLERGY; MOLECULAR CLONING; MOLECULAR MODEL; NUCLEOTIDE SEQUENCE; SEQUENCE ALIGNMENT; SF9 CELL; STRUCTURE ANALYSIS; SURFACE CHARGE;

ALLERGENS; AMINO ACID SEQUENCE; ANIMALS; BEE VENOMS; BEES; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, B-LYMPHOCYTE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INSECT BITES AND STINGS; INSECT PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, QUATERNARY; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84871265413     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bilo MB, Bonifazi F. The natural history and epidemiology of insect venom allergy: clinical implications. Clin Exp Allergy. 2009;39:1467-76.
2. Bilo MB. Anaphylaxis caused by Hymenoptera stings: from epidemiology to treatment. Allergy. 2011;66 Suppl 95:35-7.
3. Müller UR. Insektenstichallergie: Klinik, Diagnostik und Therapie. Stuttgart, New York: Gustav Fischer Verlag, 1988.
4. Muller UR. Recombinant Hymenoptera venom allergens. Allergy. 2002;57:570-576.
5. King T P, Spangfort MD. Structure and biology of stinging insect venom allergens. Int Arch Allergy Immunol. 2000;123:99-106.
6. Grunwald T, Bockisch B, Spillner E, Ring J, Bredehorst R, Ollert MW. Molecular cloning and expression in insect cells of honeybee venom allergen acid phosphatase (Api m 3). J Allergy Clin Immunol. 2006;117:848-54.
7. Blank S, Seismann H, Bockisch B, Braren I, Cifuentes L, McIntyre M, Ruhl D, Ring J, Bredehorst R, Ollert MW, Grunwald T, Spillner E. Identifi cation, recombinant expression, and characterization of the 100 kDa high molecular weight Hymenoptera venom allergens Api m 5 and Ves v 3. J Immunol. 2010;184:5403-13.
8. Peiren N, Vanrobaeys F, de Graaf DC, Devreese B, Van Beeumen J, Jacobs FJ. The protein composition of honeybee venom reconsidered by a proteomic approach. Biochim Biophys Acta. 2005;1752:1-5.
9. Peiren N, de Graaf DC, Brunain M, Bridts CH, Ebo DG, Stevens WJ, Jacobs FJ. Molecular cloning and expression of icarapin, a novel IgE-binding bee venom protein. FEBS Lett. 2006;580:4895-9.
10. Blank S, Seismann H, Michel Y, McIntyre M, Cifuentes L, Braren I, Grunwald T, Darsow U, Ring J, Bredehorst R, Ollert M, Spillner E. Api m 10, a genuine A. mellifera venom allergen, is clinically relevant but underrepresented in therapeutic extracts. Allergy. 2011;66:1322-1329.
11. Blank S, Bantleon FI, McIntyre M, Ollert M, Spillner E. The major royal jelly proteins 8 and 9 (Api m 11) are glycosylated components of Apis mellifera venom with allergenic potential beyond carbohydrate based reactivity. Clin Exp Allergy. Forthcoming 2012.
12. Peiren N, de Graaf DC, Vanrobaeys F, Danneels EL, Devreese B, Van Beeumen J, Jacobs FJ. Proteomic analysis of the honey bee worker venom gland focusing on the mechanisms of protection against tissue damage. Toxicon. 2008;52:72-83.
13. Kettner A, Hughes GJ, Frutiger S, Astori M, Roggero M, Spertini F, Corradin G. Api m 6: a new bee venom allergen. J Allergy Clin Immunol. 2001;107:914-20.
14. Peiren N, de Graaf DC, Evans JD, Jacobs FJ. Genomic and transcriptional analysis of protein heterogeneity of the honeybee venom allergen Api m 6. Insect Mol Biol. 2006;15:577-81.
15. Shkenderov S. A protease inhibitor in bee venom. Identifi cation, partial purifi cation and some properties. FEBS Lett. 1973;33:343-347.
16. Wu S, Zhang Y. LOMETS: a local meta-threading-server for protein structure prediction. Nucleic Acids Res. 2007;35:3375-3382.
17. Kulkarni-Kale U, Bhosle S, Kolaskar AS. CEP: a conformational epitope prediction server. Nucleic Acids Res. 2005;33:W168-71.
18. Ausubel FM. Current Protocols in Molecular Biology. New York: Wiley Interscience, 1996.
19. Southworth MW, Amaya K, Evans TC, Xu MQ, Perler FB. Purifi cation of proteins fused to either the amino or carboxy terminus of the Mycobacterium xenopi gyrase A intein. Biotechniques. 1999;27:110-114, 116, 118-120.
20. Shkenderov S. Further purifi cation, inhibitory spectrum and some kinetic properties of the protease inhibitor in bee venom. In: Ohsaka A, Hayashi K, Sawai Y, eds. Animal, plant, and micobial toxins. New York: Plenum; 1976. p. 263-72.
21. Bania J, Stachowiak D, Polanowski A. Primary structure and properties of the cathepsin G/chymotrypsin inhibitor from the larval hemolymph of Apis mellifera. Eur J Biochem. 1999;262:680-687.
22. Peanasky RJ, Bentz Y, Paulson B, Graham DL, Babin DR. The isoinhibitors of chymotrypsin/elastase from Ascaris lumbricoides: isolation by affi nity chromatography and association with the enzymes. Arch Biochem Biophys. 1984;232:127-34.
23. Cierpicki T, Bania J, Otlewski J. NMR solution structure of Apis mellifera chymotrypsin/cathepsin G inhibitor-1 (AMCI-1): structural similarity with Ascaris protease inhibitors. Protein Sci. 2000;9:976-84.
24. Huang K, Strynadka NC, Bernard VD, Peanasky RJ, James MN. The molecular structure of the complex of Ascaris chymotrypsin/ elastase inhibitor with porcine elastase. Structure. 1994;2:679-89.
25. Krowarsch D, Cierpicki T, Jelen F, Otlewski J. Canonical protein inhibitors of serine proteases. Cell Mol Life Sci. 2003;60:2427-44.
26. Babin DR, Peanasky RJ, Goos SM. The isoinhibitors of chymotrypsin/elastase from Ascaris lumbricoides: the primary structure. Arch Biochem Biophys. 1984;232:143-61.
27. Grasberger BL, Clore GM, Gronenborn AM. High-resolution structure of Ascaris trypsin inhibitor in solution: direct evidence for a pH-induced conformational transition in the reactive site. Structure. 1994;2:669-78.
28. Bode W, Huber R. Natural protein proteinase inhibitors and their interaction with proteinases. Eur J Biochem. 1992;204:433-51.
29. Schechter I, Berger A. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun. 1967;27:157-62.
30. Laskowski MJ, Qasim MA, M. LS. Interaction of standard mechanism, canonical protein inhibitors with serine proteinases. In: Kleanthous C., ed. Protein-Protein Recognition. Oxford: Oxford University Press; 2000. p. 228-79.
31. Buczek O, Koscielska-Kasprzak K, Krowarsch D, Dadlez M, Otlewski J. Analysis of serine proteinase-inhibitor interaction by alanine shaving. Protein Sci. 2002;11:806-19.
32. Qasim MA, Lu SM, Ding J, Bateman KS, James MN, Anderson S, Song J, Markley JL, Ganz PJ, Saunders CW, Laskowski M, Jr. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases. Biochemistry. 1999;38:7142-50.
33. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977;1:466-9.